Avicenna journal of medical biotechnology最新文献

筛选
英文 中文
5-Fluorouracil Effectively Depletes Tumor Induced Myeloid Derived Suppressor Cells in 4T1 Mammary Carcinoma Model. 5-氟尿嘧啶能有效清除 4T1 乳腺癌模型中肿瘤诱导的髓系衍生抑制细胞
Avicenna journal of medical biotechnology Pub Date : 2024-10-01 DOI: 10.18502/ajmb.v16i4.16740
Khadijeh Ramezani-Aliakbari, Seyed Amir Jalali, Maedeh Alinejad, Mahmood Jeddi-Tehrani, Mahdi Shabani
{"title":"5-Fluorouracil Effectively Depletes Tumor Induced Myeloid Derived Suppressor Cells in 4T1 Mammary Carcinoma Model.","authors":"Khadijeh Ramezani-Aliakbari, Seyed Amir Jalali, Maedeh Alinejad, Mahmood Jeddi-Tehrani, Mahdi Shabani","doi":"10.18502/ajmb.v16i4.16740","DOIUrl":"10.18502/ajmb.v16i4.16740","url":null,"abstract":"<p><strong>Background: </strong>Myeloid Derived Suppressor Cells (MDSCs) are capable of inhibiting both innate and adaptive immune responses and accumulate in the microenvironment of breast tumors. Hence, MDSC depletion by chemotherapeutic agents can improve clinical efficacy of cancer immunotherapy. The effects of 5-FU and doxorubicin agents on MDSC reduction in 4T1 breast cancer murine model were evaluated.</p><p><strong>Methods: </strong>5×10<sup>5</sup> of 4T1 tumor cells were injected into mammary fat pad of BALB/c female mice. Tumor bearing mice were randomly divided into 4 groups: PBS receiving control group, doxorubicin receiving groups at doses of 2.5 and 5 <i>mg/kg</i>, and 5-FU receiving group at dose of 50 <i>mg/kg</i>. Doxorubicin and 5-FU agents were intraperitoneally administrated at three doses with 5-day intervals and five doses for three times a week, respectively. Then, on day 20 post tumor cells injection, spleens and tumors were isolated to determine frequency of CD11b<sup>+</sup> Gr1<sup>+</sup> MDSCs by flow cytometry analysis.</p><p><strong>Results: </strong>5-FU was able to reduce significantly both splenic and interatumoral MDSCs comparing to control group (p=0.0276 and p=0.0067, respectively). Also, Doxorubicin treatment at dose of 50 <i>mg/kg</i> was associated to a significant reduction of splenic MDSCs in comparison to untreated group (p=0.0382). However, only 5-FU injection led to inhibit notably tumor growth in comparison to control group (p=0.0139).</p><p><strong>Conclusion: </strong>Findings show that 5-FU has inhibitory effects on MDSCs and tumor growth in 4T1 tumor model. So, more investigations are needed to study combination of 5-FU with immune based approaches to enhance the efficacy of cancer therapies.</p>","PeriodicalId":8669,"journal":{"name":"Avicenna journal of medical biotechnology","volume":"16 4","pages":"244-250"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11589428/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142738268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Importance of Biosecurity in Emerging Biotechnologies and Synthetic Biology. 新兴生物技术和合成生物学中生物安全的重要性。
Avicenna journal of medical biotechnology Pub Date : 2024-10-01 DOI: 10.18502/ajmb.v16i4.16738
Mahboubeh Soleimani Sasani
{"title":"The Importance of Biosecurity in Emerging Biotechnologies and Synthetic Biology.","authors":"Mahboubeh Soleimani Sasani","doi":"10.18502/ajmb.v16i4.16738","DOIUrl":"10.18502/ajmb.v16i4.16738","url":null,"abstract":"<p><p>The age of synthetic biology is ushering in new technologies for the advancement of society, human health, and agriculture. It appears that synthetic biology has integrated engineering paradigms into biological contexts. The combined use of new biotechnology and synthetic biology raises concerns about biosafety, biosecurity, and even cyberbiosecurity. For example, synthetic biology increases the possibility of designing, developing, and deploying pathogenic bioweapons in new and different ways than natural pathogens, as well as manipulating the genome. Evaluation of new technologies and platforms that enable creative or destructive manipulation of biological materials, systems, and organisms is important to identify potential security opportunities and vulnerabilities. This issue poses challenges to the medical community and civilian populations worldwide, creating a growing need to implement and enforce standardized biosafety and biosecurity regulations to protect humans, animals, plants, and the environment. It is critical to establish rules and management guidelines, provide strong leadership at the individual and institutional levels, and utilize established biosafety and biosecurity tools to mitigate the risks associated with synthetic biology. This review addresses the current state of synthetic biology, focusing on the concepts of biosafety, biosecurity, and cyberbiosecurity, as well as enhancing the standardization, regulation, and management of biosecurity in synthetic biology. In this review, the current situation in the Middle East region has been discussed and the challenges and opportunities encountered by synthetic biology researchers in this area is explored. The Middle East region is vulnerable to bioterrorism due to various factors. However, some countries in this strategically important region face challenges as they lack the necessary resources to effectively combat this significant global threat. These attacks are not limited to a specific border or area; they can affect multiple countries or have a global impact.</p>","PeriodicalId":8669,"journal":{"name":"Avicenna journal of medical biotechnology","volume":"16 4","pages":"223-232"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11589425/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142738274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunogenic Consideration of a Designed Polypeptide Against Brucellosis Compared to RB51: An In Vivo Study. 与 RB51 相比,设计多肽对布鲁氏菌病的免疫原性考虑:体内研究。
Avicenna journal of medical biotechnology Pub Date : 2024-10-01 DOI: 10.18502/ajmb.v16i4.16741
Mina Saadat, Mojgan Bandehpour, Bahram Kazemi, Nariman Mosaffa
{"title":"Immunogenic Consideration of a Designed Polypeptide Against Brucellosis Compared to RB51: An <i>In Vivo</i> Study.","authors":"Mina Saadat, Mojgan Bandehpour, Bahram Kazemi, Nariman Mosaffa","doi":"10.18502/ajmb.v16i4.16741","DOIUrl":"10.18502/ajmb.v16i4.16741","url":null,"abstract":"<p><strong>Background: </strong>Brucellosis in livestock and its transmission to humans through the consumption of contaminated dairy products is an important issue. The introduction of new approaches using immunogenic proteins against and diagnosing brucellosis is a serious issue in human health.</p><p><strong>Methods: </strong><i>Brucella abortus</i> contains five proteins including: MOXR family ATPase-α2, T9SS C-terminal target domain-containing protein, Cobyric acid synthase, Hypothetical protein, and VirB11 type IV Secretion protein, which were considered and the designed recombinant polypeptide was produced and evaluated. The pure recombinant protein ABOR with 549aa in combination with chitin as an adjuvant was injected subcutaneously into guinea pigs to evaluate their immunity responses.</p><p><strong>Results: </strong>The results indicated that the ABOR recombinant protein induced Th1 immunity with high levels of specific IgG (IgG2a) as well as Interferon-γ (IFN-γ), Interleukin-2 (IL-2), IL-12, and Tumor Necrosis Factor-alpha (TNF-α), compared to the control group. Th1/Th2 ratio analysis demonstrated the efficacy of ABOR protein combined with chitin in stimulating cellular immunity in the animals.</p><p><strong>Conclusion: </strong>Designed recombinant polypeptide combined with chitin showed ability for induction of cellular and humoral immunity an guinea pigs compared to RB51 vaccine.</p>","PeriodicalId":8669,"journal":{"name":"Avicenna journal of medical biotechnology","volume":"16 4","pages":"251-259"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11589429/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142738270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Potential of Human Wharton's Jelly Mesenchymal Stem Cells Secretome Based Topical Gel for Therapeutic Application. 基于人类沃顿果冻间充质干细胞分泌组的局部凝胶的治疗应用潜力。
Avicenna journal of medical biotechnology Pub Date : 2024-10-01 DOI: 10.18502/ajmb.v16i4.16739
Wahyu Widowati, Ahmad Faried, Rimonta Febby Gunanegara, Fanny Rahardja, Fadhilah Haifa Zahiroh, Annisa Firdaus Sutendi, Faradhina Salfa Nindya, Rizal Azis, Renandy Kristianlie Ekajaya
{"title":"The Potential of Human Wharton's Jelly Mesenchymal Stem Cells Secretome Based Topical Gel for Therapeutic Application.","authors":"Wahyu Widowati, Ahmad Faried, Rimonta Febby Gunanegara, Fanny Rahardja, Fadhilah Haifa Zahiroh, Annisa Firdaus Sutendi, Faradhina Salfa Nindya, Rizal Azis, Renandy Kristianlie Ekajaya","doi":"10.18502/ajmb.v16i4.16739","DOIUrl":"10.18502/ajmb.v16i4.16739","url":null,"abstract":"<p><strong>Background: </strong>Diabetic Foot Ulcer (DFU) might be worsened by neuropathy and vascular issues. This condition can cause 14.3% fatality, stressing the need for effective wound healing therapy. Wound healing is a complex biological process, and human Wharton's Jelly Mesenchymal Stem Cells (hWJMSCs) may help manage DFU treatment issues. This research focuses on utilizing a gel carrier to deliver bioactive substances from Wharton's Jelly Mesenchymal Stem Cells secretome (hWJ-MSCs-Sec) as a possible treatment for DFU.</p><p><strong>Methods: </strong>To maintain quality, hWJMSCs-Sec is thoroughly mixed with carbomer gel and freeze-dried. ELISA test is performed to determine the characterization of the gel of hWJMSCs-Sec such as Keratinocyte Growth Factor (KGF), Platelet-Derived Growth Factor (PDGF), Hepatocyte Growth Factor (HGF), Epidermal Growth Factor (EGF), and Heparin-Binding EGF-Like Growth Factor (HB-EGF). The antioxidant activity was also measured with Hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), Nitric oxide (NO), and Ferric Reducing Antioxidant Power (FRAP) assay. Proliferation assay was utilized using WST-8 and the wound healing potential was assessed <i>via</i> the migration cell ability of scratched-human skin fibroblast (BJ cells).</p><p><strong>Results: </strong>The freeze-dried hWJ-MSCs-Sec showed higher levels of KGF, HGF, PDGF, EGF, HB-EGF, and the antioxidant activities compared to fresh hWJ-MSCs-Sec. Additionally, the gel of freeze-dried hWJ-MSCs-Sec exhibited higher levels compared to the gel of fresh hWJMSCs-Sec. This was evidenced by faster closure of scratched wounds on BJ cells treated with hWJMSCs-Sec and freeze-dried hWJ-MSCs-Sec gel.</p><p><strong>Conclusion: </strong>The freeze-dried hWJ-MSCs-Sec gel exhibits superior quality compared to the non-freeze-dried hWJ-MSCs-Sec gel. This demonstrates that the freeze-drying procedure can maintain the bioactive chemicals found in hWJMSCs-Sec, potentially enhancing the efficacy of this gel in promoting cell regeneration for wound healing.</p>","PeriodicalId":8669,"journal":{"name":"Avicenna journal of medical biotechnology","volume":"16 4","pages":"233-243"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11589430/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142738276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Simulated Physiological Oocyte Maturation (SPOM) and L-Carnitine on Bovine Oocyte Developmental Competence. 模拟生理卵母细胞成熟(SPOM)和左旋肉碱对牛卵母细胞发育能力的影响
Avicenna journal of medical biotechnology Pub Date : 2024-10-01 DOI: 10.18502/ajmb.v16i4.16742
Ali Malekpour, Abolfazl Shirazi, Sara Borjian Boroujeni, Ali Sarvari, Mohammad Mehdi Naderi, Mostafa Pournourali, Bahareh Behzadi, Mohammad Mehdi Mehrazar
{"title":"The Effect of Simulated Physiological Oocyte Maturation (SPOM) and L-Carnitine on Bovine Oocyte Developmental Competence.","authors":"Ali Malekpour, Abolfazl Shirazi, Sara Borjian Boroujeni, Ali Sarvari, Mohammad Mehdi Naderi, Mostafa Pournourali, Bahareh Behzadi, Mohammad Mehdi Mehrazar","doi":"10.18502/ajmb.v16i4.16742","DOIUrl":"10.18502/ajmb.v16i4.16742","url":null,"abstract":"<p><strong>Background: </strong>Simulated Physiological Oocyte Maturation (SPOM) mimics <i>in vitro</i> the physiological events of oocyte maturation in the presence of cAMP modulators. These modulators increase the intracellular concentrations of cAMP, which inhibits the immediate resumption of meiosis and gives the oocyte more time to gain optimal developmental competence. In addition, L-carnitine helps to increase the energy supply of cells through the β-oxidation of fatty acids. This study aimed to investigate the effect of SPOM and L-carnitine supplementation during <i>In Vitro Maturation</i> (IVM) and <i>In Vitro</i> Culture (IVC) on the developmental competence of bovine oocytes.</p><p><strong>Methods: </strong>Ovarian Cumulus Complexes (COCs) were cultured in the presence or absence of forskolin+IBMX during the first 2 <i>hr</i> of IVM (pre-IVM) with or without L-carnitine (LC) during IVM or IVC in six experimental groups as follows: I) pre-IVM (pre-IVM group), II) pre-IVM with L-carnitine supplementation during IVM (pre-IVM/LC group), III) L-carnitine supplementation during IVM (IVM/LC group), IV) L-carnitine supplementation during <i>in vitro</i> culture (IVC/LC group), V) pre-IVM+ IVC/LC group, and VI) no treatment during IVM and IVC (Control group). The cleavage and blastocyst rates, the blastocysts' total cells number, and the expression of <i>Nanog</i>, <i>Bax</i>, <i>Oct4</i>, <i>Cdx2</i>, and <i>Ifnt</i> genes in resulting blastocysts were assessed. To assess differences among experimental groups, a one-way analysis of variance was initially employed, followed by post hoc Fisher LSD. The difference between groups was considered statistically significant when p<0.05.</p><p><strong>Results: </strong>The cleavage and blastocyst rates in the Pre-IVM and Pre-IVM/LC groups was higher than control group and other groups (p≤0.05) except for IVC/LC and IVM/LC groups, respectively. The number of blastocyst's Inner Cell Mass (ICM) in pre-IVM and Pre-IVM/LC groups as well as the ratio of ICM/TE were higher than control group (p<0.05). The expression of OCT4, CDX2, and IFNT increased in both the pre-IVM and pre-IVM/LC groups compared to the control group (p<0.05).</p><p><strong>Conclusion: </strong>In conclusion, the application of SPOM-adapted IVM and L-carnitine during IVM of bovine oocyte improves the quantity and quality of the resulting embryos.</p>","PeriodicalId":8669,"journal":{"name":"Avicenna journal of medical biotechnology","volume":"16 4","pages":"260-267"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11589426/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142738273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Generation of Optimized Consensus Sequences for Hepatitis C virus (HCV) Envelope 2 Glycoprotein (E2) by a Modified Algorithm: Implication for a Pan-genomic HCV Vaccine. 通过修改算法生成丙型肝炎病毒(HCV)包膜 2 糖蛋白(E2)的优化共识序列:泛基因组 HCV 疫苗的意义。
Avicenna journal of medical biotechnology Pub Date : 2024-10-01 DOI: 10.18502/ajmb.v16i4.16743
Reyhaneh Mohabati, Reza Rezaei, Nasir Mohajel, Mohammad Mehdi Ranjbar, Katayoun Samimi-Rad, Kayhan Azadmanesh, Farzin Roohvand
{"title":"Generation of Optimized Consensus Sequences for Hepatitis C virus (HCV) Envelope 2 Glycoprotein (E2) by a Modified Algorithm: Implication for a Pan-genomic HCV Vaccine.","authors":"Reyhaneh Mohabati, Reza Rezaei, Nasir Mohajel, Mohammad Mehdi Ranjbar, Katayoun Samimi-Rad, Kayhan Azadmanesh, Farzin Roohvand","doi":"10.18502/ajmb.v16i4.16743","DOIUrl":"10.18502/ajmb.v16i4.16743","url":null,"abstract":"<p><strong>Background: </strong>Despite the success of \"direct-acting antivirals\" in treating Hepatitis C Virus (HCV) infection, invention of a preventive HCV vaccine is crucial for global elimination of the virus. Recent data indicated the importance of the induction of Pangenomic neutralizing Antibodies (PnAbs) against heterogenic HCV Envelope 2(E2), the cellular receptor binding antigen, by any HCV vaccine candidate. To overcome HCVE2 heterogeneity, \"generation of consensus HCVE2 sequences\" is proposed. However, Consensus Sequence (CS) generating algorithms such as \"Threshold\" and \"Majority\" have certain limitations including \"Threshold-rigidity\" which leads to induction of undefined residues and insensitivity of the \"Majority\" towards the \"evolutionary cost of residual substitutions\".</p><p><strong>Methods: </strong>Herein, first a modification to the \"Majority\" algorithm was introduced by incorporating BLOSUM matrices. Secondly, the HCVE2 sequences generated by the \"Fitness\" algorithm (using 1698 sequences from genotypes 1, 2, and 3) was compared with those generated by the \"Majority\" and \"Threshold\" algorithms using several <i>in silico</i> tools.</p><p><strong>Results: </strong>Results indicated that only \"Fitness\" provided completely defined, gapless HCVE2s for all genotypes/subtypes, while considered the evolutionary cost of amino acid replacements (main \"Majority/Threshold\" limitations) by substitution of several residues within the generated consensuses. Moreover, \"Fitness-generated HCVE2 CSs\" were superior for antigenic/immunogenic characteristics as an antigen, while their positions within the phylogenetic trees were still preserved.</p><p><strong>Conclusion: </strong>\"Fitness\" algorithm is capable of generating superior/optimum HCVE2 CSs for inclusion in a pan-genomic HCV vaccine and can be similarly used in CS generation for other highly variable antigens from other heterogenic pathogens.</p>","PeriodicalId":8669,"journal":{"name":"Avicenna journal of medical biotechnology","volume":"16 4","pages":"268-278"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11589427/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142738269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overview on Immunopathology of Chronic Lymphocytic Leukemia and Tumor-Associated Antigens with Therapeutic Applications. 慢性淋巴细胞白血病的免疫病理学和治疗应用的肿瘤相关抗原概述。
Avicenna journal of medical biotechnology Pub Date : 2024-10-01 DOI: 10.18502/ajmb.v16i4.16737
Mahdi Shabani, Davoud Rostamzadeh, Mansoure Mansouri, Mahmood Jeddi-Tehrani
{"title":"Overview on Immunopathology of Chronic Lymphocytic Leukemia and Tumor-Associated Antigens with Therapeutic Applications.","authors":"Mahdi Shabani, Davoud Rostamzadeh, Mansoure Mansouri, Mahmood Jeddi-Tehrani","doi":"10.18502/ajmb.v16i4.16737","DOIUrl":"10.18502/ajmb.v16i4.16737","url":null,"abstract":"<p><p>Chronic Lymphocytic Leukemia (CLL) is a clinically and biologically heterogeneous disease with a variable clinical course. The induction of a generalized state of immuno-suppression, leading to susceptibility to infections and the failure of anti-tumor immune responses, is a key feature of the clinical course of CLL. In addition to B-cell receptor (BCR) signaling in CLL, several receptor tyrosine kinases (RTKs) have been reported to be constitutively active in leukemic B cells, resulting in promoted survival and resistance to apoptosis induced by chemotherapy. Several treatment options are available for CLL, including a watch-and-wait strategy, chemotherapy, targeted therapies, immunotherapies such as adoptive cellular therapy (CAR T-Cell Therapy), stem cell transplantation (allogeneic transplantation), radiation therapy and surgery. The identification of Tumor-Associated Antigens (TAAs) is the bottleneck of tumor immunology and immunotherapy, serving as promising targets for precise diagnosis, monitoring, or therapeutic approaches. Numerous TAAs have been identified, and their application in immunotherapy holds promise for the treatment of CLL. Furthermore, extensive ongoing research aims to identify new cancer TAAs. In this review, our objective is to provide a comprehensive overview of CLL immunology and recent findings regarding advances in TAAs with therapeutic applications in CLL.</p>","PeriodicalId":8669,"journal":{"name":"Avicenna journal of medical biotechnology","volume":"16 4","pages":"201-222"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11589431/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142738272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Need to Continue the Education of Medical Doctors in Medical Basic Science: Existing Obstacles. 继续对医生进行医学基础科学教育的必要性:现有障碍。
Avicenna journal of medical biotechnology Pub Date : 2024-10-01 DOI: 10.18502/ajmb.v16i4.16736
Shahin Akhondzadeh
{"title":"The Need to Continue the Education of Medical Doctors in Medical Basic Science: Existing Obstacles.","authors":"Shahin Akhondzadeh","doi":"10.18502/ajmb.v16i4.16736","DOIUrl":"10.18502/ajmb.v16i4.16736","url":null,"abstract":"","PeriodicalId":8669,"journal":{"name":"Avicenna journal of medical biotechnology","volume":"16 4","pages":"200"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11589432/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142738275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimization of the Production of Soluble Recombinant TEV Protease in Two E. coli Strains. 在两种大肠杆菌菌株中生产可溶性重组 TEV 蛋白酶的优化。
Avicenna journal of medical biotechnology Pub Date : 2024-10-01 DOI: 10.18502/ajmb.v16i4.16744
Matineh Shahriari, Fatemeh Shafiee, Fatemeh Moazen, Hamid Mir Mohammad Sadeghi
{"title":"Optimization of the Production of Soluble Recombinant TEV Protease in Two <i>E. coli</i> Strains.","authors":"Matineh Shahriari, Fatemeh Shafiee, Fatemeh Moazen, Hamid Mir Mohammad Sadeghi","doi":"10.18502/ajmb.v16i4.16744","DOIUrl":"10.18502/ajmb.v16i4.16744","url":null,"abstract":"<p><strong>Background: </strong>The low solubility of Tobacco Etch Virus (TEV) protease, a functional enzyme that cleaves protein tags without significant modification in its sequence, is one of the most important limitations of this enzyme. In this study, the aim was to increase the solubility of TEV by changing the expression conditions and designing lysis buffer with various solubilizing agents to improve its solubility.</p><p><strong>Methods: </strong><i>Escherichia coli</i> (<i>E</i>. <i>coli</i>) BL21 (DE3) and <i>E. coli</i> origami harboring wild type TEV-pKR793 and mutant N23F TEV-pKR793 plasmids were used for the expression. Response surface methodology was used to determine the best culture conditions (IPTG concentration, incubation time and incubation temperature) of soluble expression. Furthermore, eight different solubilizing agents were added separately to the lysis buffer to check their effect on the protein solubility.</p><p><strong>Results: </strong>The production of soluble N23F in <i>E. coli</i> BL21 (DE3) was two-folds more than the wild type and the inclusion body formation in the mentioned form was diminished as about 25% in comparison to the wild type. Finally, betaine had the most effects for enhancing the soluble expression of N23F in both host cells. For the wild type, sodium selenite, xylitol, and glycine showed the most effects on soluble production.</p><p><strong>Conclusion: </strong>The solubility of the mutant form of TEV protease increased in <i>E. coli</i> BL21 (DE3) compared to its wild form. Also, using additives such as betaine to the lysis buffer, increased the solubility of N23F in <i>E. coli</i> BL21 (DE3) and origami strains.</p>","PeriodicalId":8669,"journal":{"name":"Avicenna journal of medical biotechnology","volume":"16 4","pages":"279-283"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11589424/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142738271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Studying the Effect of Magnetron Copper Deposition on the Surface Topography of Biodegradable Antibacterial Coating. 研究磁控管沉铜对生物降解抗菌涂层表面形貌的影响
Avicenna journal of medical biotechnology Pub Date : 2024-07-01 DOI: 10.18502/ajmb.v16i3.15743
Maratuly Bauyrzhan, Bagdat Nurlanovich Azamatov, Alexey Vladimirovich Jes
{"title":"Studying the Effect of Magnetron Copper Deposition on the Surface Topography of Biodegradable Antibacterial Coating.","authors":"Maratuly Bauyrzhan, Bagdat Nurlanovich Azamatov, Alexey Vladimirovich Jes","doi":"10.18502/ajmb.v16i3.15743","DOIUrl":"10.18502/ajmb.v16i3.15743","url":null,"abstract":"<p><strong>Background: </strong>The surface properties of the materials used significantly influence the success and longevity of medical implants. Increasing surface roughness promotes osteoblast activity and osseointegration, while biodegradable materials such as copper have shown potential for antimicrobial applications. However, the effect of coating parameters on surface topography is not well investigated.</p><p><strong>Methods: </strong>Sputtering of copper was performed using EPOS-PVD-440 system (Zeleno-grad, Russia). The samples were examined by Scanning Electron Microscopy (SEM) with subsequent image processing in Mountains software (Digital Surf). Antibacterial efficacy was evaluated against Staphylococcus aureus by measuring the zone of inhibition. Additionally, copper ion release was monitored over time to assess its correlation with changes in surface topography.</p><p><strong>Results: </strong>Higher sputtering currents increased surface roughness and particle size, with a significant release of copper ions within the first 24 <i>hr</i> of immersion. Samples sputtered at higher currents exhibited coarser grain structures. The release of copper ions in the simulated biological environment led to further changes in surface topography, highlighting the critical influence of sputtering parameters on coating properties.</p><p><strong>Conclusion: </strong>Optimizing magnetron copper deposition parameters enhances the surface topography and antibacterial effectiveness of biodegradable coatings on implants.</p>","PeriodicalId":8669,"journal":{"name":"Avicenna journal of medical biotechnology","volume":"16 3","pages":"174-179"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11316509/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141916006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信